They found that the overexpression of ALDH1 was observed in paclitaxel- and topotecan-resistant cell lines, indicating that ALDH1-positive cancer cells were related to drug resistance and tumor development in ovarian cancer31. The gene discussed is ALDH1A1; the disease is neoplasm.